Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Esslingen, DEU
Life Science Center Esslingen
Schelztorstraße 54-56
Esslingen, 73728, DEU

Funding

TOTAL $989k
FUNDING TOTAL $989k
Venture Round, 1/2010
High-Tech Gruenderfonds
Life Science Fonds Esslingen
€700k

Tags

Amedrix

The Amedrix GmbH develops solutions based on native collagen medical devices for the regeneration of soft tissue defects, eg for the regeneration of skin defects. The matrices are used as three-dimensional cell carrier materials in the body’s own cells migrate, proliferate and regenerate the defective tissue. A biopsy on the patient in advance is no longer necessary. Among the products are collagen solutions, gels, membrane, sponges and fleeces in the form, size and thickness are so variable that a wide range of defect is standard treatment possible. Collagen nukleinsäurefrei this is made with a specially developed process.

Recent Milestones

  • Dollar
    Amedrix received $989k (€700k) in Venture Round funding. (1/20/10)
    Posted 1/20/10 at 6:11pm via finsmes.com

Videos

Screenshots

Amedrix screenshot
Above: Home Page
Uploaded: 1/21/10

Sources

  1. Germany, Amedrix Raises €700,000 in Start up Financing (finsmes.com) [edit]
Edit This Page
Last Edited 1/20/10

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy